Vietnam Plasma Fractionation Market Opportunity, Trends, and Business Strategies With Key Players Analysis 2027
Vietnam is a potentially large healthcare market where the presence of the public sector is overwhelming the private sector, accounting for 85% of hospitals.
PORTLAND, OREGON, US, August 9, 2022 /EINPresswire.com/ -- The plasma fractionation market in Vietnam is mainly driven by the prevalent disease conditions in the population, including the increase in geriatric individuals prone to many diseases, which increases the demand for plasma based approaches to treat diseases, especially immune and neurological disorders. According to a new report published by Allied Market Research, says, the Vietnam plasma fractionation market size was valued at $56.62 million in 2019, and is expected to reach $79.03 million by 2027, registering a CAGR of 5.3% from 2020 to 2027. Blood is made up of solid components such as platelets, red blood cells, white blood cells, and a liquid component called plasma.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ@ https://www.alliedmarketresearch.com/request-sample/6803
๐๐๐ญ ๐๐ฉ ๐๐จ ๐๐% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ, ๐๐ข๐ฅ๐ฅ ๐ญ๐ก๐ ๐๐๐ญ๐ ๐๐๐ญ๐ก ๐จ๐ ๐๐ฎ๐ ๐ฎ๐ฌ๐ญ ๐๐๐๐.
๐๐๐๐๐ข๐ง๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
โข Baxter International Inc.
โข Biotest Ag
โข Bio Products Laboratory Ltd.
โข Getz Healthcare
โข Grifols Sa
โข Kedrion Biopharma
โข Octapharma
โข Novo Nordisk
โข Sanova Healthcare
โข Sanquin Blood Supply Foundation
โข Takeda Pharmaceutical Company Limited
On the other hand, Vietnam is a potentially large healthcare market where the presence of the public sector is overwhelming the private sector, accounting for more than 85% of hospitals and commune health stations nationwide. According to the World Bank Group, Vietnam is considered a middle-income country with healthcare spending at 5.53% of its GDP. To succeed as a middle-income country, the Vietnamese government is currently focusing on building core public health capacities in workforce development, diseases surveillance, emergency management, laboratory systems, and others for prevention and control of diseases.
The pre-existing medical conditions in the Vietnamese population, owing to the side effects of the Second Indochina War coupled with aging population is anticipated to drive the growth of the Vietnam plasma fractionation market. In addition, unavailability of the substitutes for plasma fractionated products is expected to drive the market growth in Vietnam, since these products cannot be replaced owing to their histocompatibility, post-translational modifications, and absence of recombinant approaches for replication of these proteins.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ@ https://www.alliedmarketresearch.com/purchase-enquiry/6803
The Vietnam plasma fractionation market is segmented on the basis of product, application, and end user. By product, the market is classified into albumin, immunoglobulins, coagulation factor VIII, and Coagulation factor IX. Under immunoglobulin segment, the Vietnam plasma fractionation market is further bifurcated in to intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG). By application, the market is categorized into neurology, hematology, immunology, critical care, and others. By end user, the Vietnam plasma fractionation market is bifurcated into hospitals and clinical research laboratories.
๐๐๐ฒ ๐
๐ข๐ง๐๐ข๐ง๐ ๐ฌ
โข Based on product, the immunoglobulin segment was the highest contributor in 2019, growing at a CAGR of 5.6% during the forecast period.
โข Based on application, the neurology segment was the largest contributor in 2019, and is expected to grow at a CAGR of 5.9%.
โข On the basis of end user, the hospitals segment is likely to dominate the Vietnam plasma fractionation market in the forecast year.
๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐๐๐ช๐ฎ๐๐ฌ๐ญ@ https://www.alliedmarketresearch.com/request-for-customization/6803
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Atherectomy Device Market
Single Use Assemblies Market
๐๐ ๐๐ฅ๐ฌ๐จ ๐๐๐๐๐ซ๐ฌ ๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
โข North America Vietnam plasma fractionation market
โข Japan Vietnam plasma fractionation market
โข South Korea Vietnam plasma fractionation market
โข Singapore Vietnam plasma fractionation market
โข Australia Vietnam plasma fractionation market
โข Europe Vietnam plasma fractionation market
โข China Vietnam plasma fractionation market
โข Taiwan Vietnam plasma fractionation market
โข New Zealand Vietnam plasma fractionation market
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.